Wealth Enhancement Advisory Services LLC Purchases 79 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

Wealth Enhancement Advisory Services LLC grew its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 1.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,879 shares of the company’s stock after purchasing an additional 79 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Inspire Medical Systems were worth $1,461,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of INSP. True Wealth Design LLC purchased a new position in shares of Inspire Medical Systems during the third quarter worth approximately $30,000. Farther Finance Advisors LLC raised its position in Inspire Medical Systems by 1,158.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 151 shares of the company’s stock worth $32,000 after purchasing an additional 139 shares during the period. GAMMA Investing LLC raised its position in Inspire Medical Systems by 559.3% in the 3rd quarter. GAMMA Investing LLC now owns 178 shares of the company’s stock worth $38,000 after purchasing an additional 151 shares during the period. Quarry LP lifted its stake in Inspire Medical Systems by 105.4% in the second quarter. Quarry LP now owns 343 shares of the company’s stock worth $46,000 after purchasing an additional 176 shares during the last quarter. Finally, Daiwa Securities Group Inc. purchased a new stake in Inspire Medical Systems during the second quarter valued at about $53,000. 94.91% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on INSP shares. Royal Bank of Canada reiterated an “outperform” rating and issued a $260.00 price objective on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Bank of America raised Inspire Medical Systems from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $220.00 to $255.00 in a research note on Wednesday, November 20th. Truist Financial reissued a “buy” rating and set a $240.00 price objective (up previously from $217.00) on shares of Inspire Medical Systems in a research note on Monday, September 30th. Robert W. Baird lifted their target price on shares of Inspire Medical Systems from $240.00 to $252.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 5th. Finally, Wells Fargo & Company increased their price target on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 5th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, Inspire Medical Systems currently has an average rating of “Moderate Buy” and a consensus target price of $233.58.

Inspire Medical Systems Trading Up 3.7 %

NYSE:INSP opened at $176.27 on Thursday. The company has a 50-day moving average price of $190.78 and a 200-day moving average price of $184.55. The stock has a market cap of $5.28 billion, a price-to-earnings ratio of 164.74 and a beta of 1.32. Inspire Medical Systems, Inc. has a 12 month low of $123.00 and a 12 month high of $257.40.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.06 by $0.54. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The business had revenue of $203.20 million during the quarter, compared to analyst estimates of $197.59 million. During the same period last year, the business posted ($0.29) earnings per share. Inspire Medical Systems’s quarterly revenue was up 32.6% compared to the same quarter last year. Equities analysts forecast that Inspire Medical Systems, Inc. will post 1.33 EPS for the current fiscal year.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.